Teplizumab changed the T1D trial landscape. Now more immune therapies, stem cell approaches, and beta cell preservation trials are recruiting. Here's what's available.
About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.
What You Need to Know
Clinical trials for type 1 diabetes are testing immune therapies to preserve beta cells, delay onset, and potentially reverse the disease in newly diagnosed patients.
Find recruiting trials for your condition
Search ClinicalTrials.gov in real time — matched to your profile, explained in plain English. Free, no account required.
Start Free Search →How Tidera Health Can Help
Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.
Enter your condition and location to see currently recruiting trials matched to your profile — with plain-English eligibility explanations and questions to ask the research coordinator.